Manufacturing is dead. Long live manufacturing!

On the same day that AstraZeneca has announced that it intents to completely outsource all of its drug manufacturing, citing the prevalence of external parties who can do it better and cheaper, Sanofi has announced plans to increase it’s biotechnology presence, particularly in manufacturing.